RENIN INHIBITORS CONTAINING HYDROPHILIC GROUPS - TETRAPEPTIDES WITH ENHANCED AQUEOUS SOLUBILITY AND NANOMOLAR POTENCY

被引:47
作者
BOCK, MG [1 ]
DIPARDO, RM [1 ]
EVANS, BE [1 ]
FREIDINGER, RM [1 ]
RITTLE, KE [1 ]
PAYNE, LS [1 ]
BOGER, J [1 ]
WHITTER, WL [1 ]
LAMONT, BI [1 ]
ULM, EH [1 ]
BLAINE, EH [1 ]
SCHORN, TW [1 ]
VEBER, DF [1 ]
机构
[1] MERCK SHARP & DOHME RES LABS, RAHWAY, NJ 07065 USA
关键词
D O I
10.1021/jm00118a009
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
引用
收藏
页码:1918 / 1923
页数:6
相关论文
共 34 条
  • [1] ABIKO T, 1981, J APPL BIOCHEM, V3, P570
  • [2] SOLID-PHASE SYNTHESIS OF A SOLUBLE PEPSTATIN DERIVATIVE SUITABLE FOR THERAPEUTIC USE
    AUSTEN, BM
    FORD, TF
    GRANT, DAW
    HERMONTAYLOR, J
    [J]. BIOSCIENCE REPORTS, 1982, 2 (06) : 427 - 432
  • [3] STATINE-CONTAINING RENIN INHIBITOR - DISSOCIATION OF BLOOD-PRESSURE LOWERING AND RENIN INHIBITION IN SODIUM-DEFICIENT DOGS
    BLAINE, EH
    SCHORN, TW
    BOGER, J
    [J]. HYPERTENSION, 1984, 6 (02) : I111 - I118
  • [4] RENIN INHIBITORS - STATINE-CONTAINING TETRAPEPTIDES WITH VARIED HYDROPHOBIC CARBOXY TERMINI
    BOCK, MG
    DIPARDO, RM
    EVANS, BE
    RITTLE, KE
    BOGER, J
    POE, M
    LAMONT, BI
    LYNCH, RJ
    ULM, EH
    VLASUK, GP
    GREENLEE, WJ
    VEBER, DF
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1987, 30 (10) : 1853 - 1857
  • [5] BOCK MG, 1985, PEPTIDES STRUCTURE F, P751
  • [6] RENIN INHIBITORS - SYNTHESES OF SUBNANOMOLAR, COMPETITIVE, TRANSITION-STATE ANALOG INHIBITORS CONTAINING A NOVEL ANALOG OF STATINE
    BOGER, J
    PAYNE, LS
    PERLOW, DS
    LOHR, NS
    POE, M
    BLAINE, EH
    ULM, EH
    SCHORN, TW
    LAMONT, BI
    LIN, TY
    KAWAI, M
    RICH, DH
    VEBER, DF
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1985, 28 (12) : 1779 - 1790
  • [7] BOGER J, 1983, NATURE, V303, P5912
  • [8] COMPETITIVE INHIBITORS OF RENIN INHIBITORS EFFECTIVE AT PHYSIOLOGICAL PH
    BURTON, J
    POULSEN, K
    HABER, E
    [J]. BIOCHEMISTRY, 1975, 14 (17) : 3892 - 3898
  • [9] BURTON J, 1981, ADV PHARM THERAPEU 2, V3, P231
  • [10] CORVOL P, 1981, ADV PHARM THERAPEU 2, V3, P243